⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL345338 | 1.00 | — | — | |
| SCHEMBL11503186 | 1.00 | — | — | |
| SCHEMBL21114332 | 1.00 | — | — | |
| SCHEMBL21114229 | 1.00 | — | — | |
| SCHEMBL6587101 | 1.00 | — | — | |
| SCHEMBL21114285 | 1.00 | — | — | |
| SCHEMBL345376 | 0.96 | — | — | |
| SCHEMBL28303932 | 0.92 | — | — | |
| SCHEMBL1486286 | 0.84 | — | — | |
| SCHEMBL498103 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109790284-B | Polyphenol compound and process for producing the same | 三菱化学株式会社 | 2021-09-21 | — | — | CN | disclosed |
| US-10851039-B2 | Polyhydric phenol compound and method of producing same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-12-01 | — | — | US | disclosed |
| US-10793499-B2 | — | — | 2020-10-06 | — | — | US | disclosed |
| EP-3514193-A1 | POLYVALENT PHENOL COMPOUND AND METHOD OF PRODUCING SAME | Mitsubishi Chemical Corporation (JP) | 2019-07-24 | — | — | EP | disclosed |
| US-20190210947-A1 | POLYHYDRIC PHENOL COMPOUND AND METHOD OF PRODUCING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-07-11 | — | — | US | disclosed |
| CN-109790284-A | Polyphenol compound and process for producing the same | 三菱化学株式会社 | 2019-05-21 | — | — | CN | disclosed |
| EP-0823423-B1 | 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES | BANYU PHARMA CO LTD (JP) | 2004-06-16 | — | — | EP | disclosed |
| US-6140338-A | FOR TREATING ACUTE INFLAMMATORY DISEASES, CHRONIC INFLAMMATORY DISEASES, ACQUIRED IMMUNE DEFICIENCY SYNDROME, CANCER, ISCHEMIC REFLOW DISORDER AND/OR ARTERIOSCLEROSIS | BANYU PHARMACEUTICAL, CO., LTD. (JP) | 2000-10-31 | — | — | US | disclosed |
| US-6040449-A | USEFUL FOR FORMING FLUORINE CONTAINING 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES, USEFUL AS ANTAGONIST FOR MUSCARINIC M3 RECEPTORS AND LESS SIDE EFFECT | BANYU PHARMACEUTICAL CO LTD (JP) | 2000-03-21 | — | — | US | disclosed |
| US-5948792-A | POTENT AND SELECTIVE ANTAGONISTS FOR MUSCARINIC M.SUB.3 RECEPTORS WITH LITTLE SIDE EFFECTS. | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1999-09-07 | — | — | US | disclosed |
| EP-0930298-A1 | FLUORINATED 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1999-07-21 | — | — | EP | disclosed |
| EP-0916668-A1 | CHEMOKINE RECEPTOR ANTAGONISTS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1999-05-19 | — | — | EP | disclosed |
| US-5750540-A | SIDE EFFECT REDUCTION | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1998-05-12 | — | — | US | disclosed |
| EP-0823423-A1 | 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1998-02-11 | — | — | EP | disclosed |